Article
Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.
The Journal of infectious diseases - 1 Dec 1998
van Rij R P, de Roda Husman A M, Brouwer M, Goudsmit J, Coutinho R A, Schuitemaker H
Abstract excerpt
The effect of a valine to isoleucine switch in the CCR2 first transmembrane domain (CCR2 64I) on the clinical course of human immunodeficiency virus type 1 (HIV-1) infection was analyzed in relation to the presence or absence of syncytium-inducing (SI) HIV-1 variants. Compared with persons with a wild-type genotype for CCR2 and CCR5, subjects with a CCR2-64I/+ or 64I/64I (but CCR5 wild-type homozygous genotype)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.